Catalysts for Samsung Bioepis Co Ltd
65 tracked
Apr 15, 2026
approval
ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval
ONTRUZANT
→
Mar 30, 2026
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
Mar 19, 2026
approval
OPUVIZ (AFLIBERCEPT-YSZY) — FDA approval
OPUVIZ
→
Jan 23, 2026
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Dec 5, 2025
approval
ETICOVO (ETANERCEPT-YKRO) — FDA approval
ETICOVO
→
Dec 5, 2025
approval
ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval
ONTRUZANT
→
Nov 28, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Nov 18, 2025
approval
PYZCHIVA (USTEKINUMAB-TTWE) — FDA approval
PYZCHIVA
→
Nov 18, 2025
approval
PYZCHIVA (USTEKINUMAB-TTWE) — FDA approval
PYZCHIVA
→
Nov 12, 2025
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
Nov 10, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Nov 5, 2025
recall
Samsung Bioepis Co., Ltd. recall (Cls II)
Samsung Bioepis Co Ltd
→
Oct 29, 2025
approval
DENOSUMAB-DSSB — FDA approval
denosumab biosimilar
→
Oct 28, 2025
approval
RENFLEXIS (INFLIXIMAB-ABDA) — FDA approval
infliximab biosimilar
→
Oct 17, 2025
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Sep 2, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Aug 25, 2025
approval
OPUVIZ (AFLIBERCEPT-YSZY) — FDA approval
OPUVIZ
→
Aug 15, 2025
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
Jun 27, 2025
approval
PYZCHIVA (USTEKINUMAB-TTWE) — FDA approval
PYZCHIVA
→
Jun 23, 2025
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Jun 6, 2025
approval
OPUVIZ (AFLIBERCEPT-YSZY) — FDA approval
OPUVIZ
→
May 21, 2025
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
May 21, 2025
approval
HADLIMA (ADALIMUMAB-BWWD) — FDA approval
HADLIMA
→
Apr 30, 2025
approval
PYZCHIVA (USTEKINUMAB-TTWE) — FDA approval
PYZCHIVA
→
Apr 30, 2025
approval
PYZCHIVA (USTEKINUMAB-TTWE) — FDA approval
PYZCHIVA
→
Apr 30, 2025
approval
PYZCHIVA (USTEKINUMAB-TTWE) — FDA approval
PYZCHIVA
→
Apr 30, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Mar 13, 2025
approval
PYZCHIVA (USTEKINUMAB-TTWE) — FDA approval
PYZCHIVA
→
Mar 13, 2025
approval
PYZCHIVA (USTEKINUMAB-TTWE) — FDA approval
PYZCHIVA
→
Mar 12, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→